Acuvi AB (ACUVI) Fair Value & Analysis
Technology · SE · Market cap 386M SEK
Fair value as of: Jul 13, 2026
From 2 valuation models · updated today
Share price −4.6% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 10.64 – kr 29.60 · fair‑value band kr 4.56 – kr 7.92 · the kr 11.56 price screens above the kr 6.24 fair value. As of Jul 13, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Acuvi AB (ACUVI) currently trades at kr 11.56, while our model-based Fair Value estimate is kr 6.24 — implying the stock looks roughly 46.0% overvalued today. We read business quality at 25/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Acuvi AB generated revenue of 204M SEK at a net margin of -13.7%. Revenue grew 0.4% year over year. It earns a return on equity of -6.8%. Net debt stands at 19.2M SEK. Fundamentals as of Jul 13, 2026
Our scenario range runs from kr 4.56 (bear case) to kr 7.92 (bull case); at kr 11.56, the current price sits above that range. The share trades about 62% below its 52-week high and 9% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -78% fair-value upside — at -46%, ACUVI screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 13, 2026. TTM = trailing twelve months.
About the company
Acuvi AB provides engineering products for OEM solutions in Sweden and internationally. The company offers linear actuators, which includes Piezo LEGS vacuum capable and non-magnetic linear motors and actuators; linear and rotary stages; microplate robots; rotary piezo legs motors; controlling the actuator/motor; custom linear actuators; custom curved rail systems; and corrosion resistant telescopic slides. It also provides solutions in the field of life science instrumentations. The company was formerly known as PiezoMotor Uppsala AB (publ) and changed its name to Acuvi AB in April 2022. Acuvi AB was incorporated in 1997 and is based in Uppsala, Sweden.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Acuvi AB reported revenue of kr 204M in FY2025 versus kr 51.4M in FY2021, a compound +41.1%/yr. Reported net income was −kr 15.3M in FY2025.
Is ACUVI fairly valued? → Check now
Similar stocks
10 more Electronic Components stocks, each showing price versus our Fair Value estimate (as of Jul 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Hon Hai Precision Industry Co HHPD | $19.66 | $19.47 | -1% |
| Amphenol Corporation A1PH34 | R$438.88 | R$50.16 | -89% |
| Delta Electronics, Inc 2308 | 2,300 TWD | 773.84 TWD | -66% |
| Samsung Electro-Mechanics Co 009150 | 1,000,000 KRW | 169,192 KRW | -83% |
| Luxshare Precision Industry Co 002475 | ¥68.77 | ¥52.40 | -24% |
| Elite Material Co 2383 | 5,700 TWD | 715.25 TWD | -87% |
| Yageo Corporation 2327 | 1,020 TWD | 222.67 TWD | -78% |
| Shengyi Technology Co 600183 | ¥184.50 | ¥27.45 | -85% |
| Victory Giant Technology (HuiZhou) Co 300476 | ¥330.26 | ¥87.71 | -73% |
| Chaozhou Three-Circle (Group) Co 300408 | ¥134.83 | ¥29.03 | -78% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Acuvi AB (ACUVI) undervalued?
What is the fair value of ACUVI?
What is the quality score of ACUVI?
What is the revenue of Acuvi AB (ACUVI)?
What is the net profit margin of ACUVI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Acuvi AB analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.